4.9 • 806 Ratings
🗓️ 21 November 2020
⏱️ 7 minutes
🧾️ Download transcript
Click on a timestamp to play from that location
0:00.0 | So, guys, Derek, moreplace, one of these.com. |
0:01.9 | Today we are going to be talking about vitamin D and nandrolone. |
0:05.6 | So this is something that a few people have sent me. |
0:08.7 | And it's kind of interesting how it's kind of resurfacing, I guess, because it's from 2012, June 25th. |
0:15.8 | So Orga Next Research, addition of vitamin D improved safety profile of Nandrolone. A recent in vitro |
0:22.6 | study by the Dutch company OrganX research demonstrates that addition of vitamin D to |
0:28.3 | nandrolone not only synergistically stimulates the proliferation of skeletal muscle stem |
0:33.1 | cells, but also improves the safety profile of nandrolone. OrganX research is developing |
0:38.9 | NDD, a new medicine combining nandrolone dekano weight and vitamin D3 to support the recovery |
0:44.8 | of elderly patients and hip fractures. It's like, I don't know why you just don't supplement it |
0:50.2 | separately. It's not like vitamin D is some special thing and needs to be a compounded |
0:54.6 | with Nandvilum de can weight but okay each year 310,000 people in the US and almost |
0:59.6 | 800,000 people in Europe suffer from hip fractures and these numbers are expected to |
1:03.6 | increase as the population ages hip fractures are a persistent cause of excessive |
1:08.3 | morbidity reduce life quality and premature mortality |
1:12.4 | among older people. Among survivors, 50% need assistance to walk and 90% need assistance |
1:17.5 | to climb stairs after one year. Among women who lived independently before hip fracture, |
1:22.2 | about half remain in long-term care or need help with the activities of daily living |
1:26.5 | one year after the event. |
1:28.0 | Currently there is no drug intervention therapy available to address the debilitating |
1:32.4 | consequences of slow end or partial recovery of hip fracture patients. |
1:37.7 | What's interesting is that's exactly what LGD 4033 is in, was in phase two trials for and probably what a lot of SARMs are going to be targeted at in the future. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from More Plates More Dates, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of More Plates More Dates and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.